Hairy Cell Leukemia (HCL) Recruiting Phase 2 Trials for Binimetinib (DB11967)

Also known as: Hairy-cell Leukemia / Hairy cell leukaemia / Hairy Cell Leukemia / Leukemia, Hairy Cell / Leukemic reticuloendotheliosis / Hairy cell leukemia (disorder) / Hairy cell leukemia (morphologic abnormality) / Hairy cell leukemia with failed remission / Leukemic reticuloendotheliosis -RETIRED- / Leukaemic reticuloendotheliosis / Leukemic reticuloendotheliosis NOS (disorder) / Leukemic reticuloendotheliosis of unspecified sites (disorder) / [M]Leukaemic reticuloendotheliosis

IndicationStatusPhase
DBCOND0046776 (Hairy Cell Leukemia (HCL))Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04324112Encorafenib Plus Binimetinib for People With BRAF V600 Mutated Relapsed/Refractory HCLTreatment
NCT04322383Binimetinib for People With Relapsed/Refractory BRAF Wild Type Hairy Cell Leukemia and VariantTreatment